Yep, the market seems to have completely ignored the fact that 40% of the "downgrade" of $4.1 million was in fact simply deferred until next FY.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025